Abstract
AbstractIn the UK, most adults with hypertension are managed in Primary Care. Referrals to Secondary Care Hypertension Specialists are targeted to patients in whom further investigations are likely to change management decisions. In this position statement the British and Irish Hypertension Society provide clinicians with a framework for referring patients to Hypertension Specialists. Additional therapeutic advice is provided to optimise patient management whilst awaiting specialist review. Our aim is to ensure that referral criteria to Hypertension Specialists are consistent across the UK and Ireland to ensure equitable access for all patients.
Publisher
Springer Science and Business Media LLC
Reference10 articles.
1. National Institute for Health and Care Excellence. Hypertension in adults: diagnosis and management. NICE guideline [NG136]. Updated 2022. Accessed 23/10/2023. https://www.nice.org.uk/guidance/ng136
2. National Institute for Health and Care Excellence. Surveillance Report: 2023 surveillance of hypertension in adults: diagnosis and management (NICE guideline NG136) and transient loss of consciousness (‘blackouts’) in over 16s (NICE guideline CG109). Updated Feb 2023. Accessed 23/10/2023. https://www.nice.org.uk/guidance/ng136/evidence
3. National Institute for Health and Care Excellence. Hypertension in pregnancy: diagnosis and management. NICE guideline [NG133]. 2019. Accessed 23/10/2023. https://www.nice.org.uk/guidance/ng133
4. Williams B, Mancia G, Spiering W, Agabiti-Rosei E, Azizi M, Burnier M, et al. Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J. 2018;38:3021–104. https://doi.org/10.1093/eurheartj/ehy339
5. Mancia G, Kreutz R, Brunström M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023;41:1874–2071. https://doi.org/10.1097/HJH.0000000000003480